Bionano Genomics Announces Issuance of Two U.S. Patents for Novel Methods that Expand Patent Protection for Uses of Nanochannel Arrays in Genome AnalysisGlobeNewsWire • 04/14/22
Bionano Genomics Announces Release of Version 6.2 of its NxClinical Software with Significant New Capabilities for Cancer Research Applications Including HRD AnalysisGlobeNewsWire • 04/07/22
Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin at 2nd Annual Maxim Group Virtual Growth Conference (Transcript)Seeking Alpha • 03/30/22
Bionano Genomics Announces Publication of Comprehensive Validation of Optical Genome Mapping for Hematologic NeoplasmsGlobeNewsWire • 03/18/22
Bionano Genomics to Present at the 32nd Annual Oppenheimer Healthcare ConferenceGlobeNewsWire • 03/08/22
Bionano Genomics' (BNGO) CEO Erik Holmlin on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/02/22
Bionano Genomics to Report Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call and Webcast on March 1st, 2022GlobeNewsWire • 02/22/22
Bionano Genomics Announces First Publication Demonstrating OGM as an Alternative to Karyotyping for Product of Conception Sample AnalysisGlobeNewsWire • 02/11/22
Bionano Genomics to Present at the 2022 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/09/22